Clinical studies recruiting near Dortmund

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Klinikum Dortmund gGmbH · Princess Maxima Center for Pediatric Oncology · NCT05327894 Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
Phase 3 · Klinikum Dortmund · AGO Study Group · NCT05009082 Resorbable Magnesium Scaffolds Registry
Phase N/A · Klinikum Westfalen, Knappschaft KH · Biotronik AG · NCT04679740 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Diabeteszentrum Dortmund · Amgen · NCT07037433 A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chr
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07549516 International HIT-MED Registry (I-HIT-MED)
Phase N/A · Klinikum Dortmund · Universitätsklinikum Hamburg-Eppendorf · NCT02417324 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · Gemeinschaftspraxis für Hämatologie und Onkologie (Gefos) · Loxo Oncology, Inc. · NCT05254743 PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS
Phase N/A · Klinikum Dortmund gGmbH, Beurhausstr.40 · Women's Cancer Study Group GmbH · NCT05792150 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of
Phase N/A · Klinikum Dortmund · Goethe University · NCT02872987 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Klinikum Dortmund gGmbH · Boehringer Ingelheim · NCT06531824 Post-Marketing Surveillance of Vliwazell® Prowound Dressing
Phase N/A · ORGAMed · Lohmann & Rauscher · NCT07316556 Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06517719 Post-Market Clinical Follow Up Study With Navitor Valve
Phase N/A · St Johannes Hospital Dortmund · Abbott Medical Devices · NCT06008080 Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of
Phase 3 · Research Site · AstraZeneca · NCT06921785 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Local Institution - 0469 · Bristol-Myers Squibb · NCT06561386 The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subje
Phase 4 · LWL-Klinik Dortmund, Bereich Forschung & Wissenschaft · Dr. Inge Winter · NCT05958875 A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in
Phase N/A · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06830720 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT07517263 Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma
Phase 3 · St. Johannes Hospital Dortmund · University of Heidelberg Medical Center · NCT06216158 A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based
Phase 2 · Klinikum Dortmund - Klinikum der Universität Witten Herdecke · North Eastern German Society of Gynaecological Oncology · NCT05460000 International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Phase 3 · Klinikum Dortmund gGmbH, Klinik für Kinder- und Jugendmedizi · University Hospital Muenster · NCT04043494 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Phase 3 · Klinikum Dortmund, Klinik f. Kinder- und Jugendmedizin · Martin Schrappe · NCT03643276 A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Ca
Phase 3 · Site 178 · Merus B.V. · NCT06525220 Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to
NA · St. Johannes Hospital · Nova Eye, Inc. · NCT05564091 STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease
Phase 3 · Klinikum Dortmund gGmbH · University of Cologne · NCT07280585 Registry for Patients With X-Linked Hypophosphatemia
Phase N/A · MVZ Dr. Eberhard & Partner · Kyowa Kirin Pharmaceutical Development Ltd · NCT03193476 Sterile Allogeneic Spongioflex® Allograft as Partial Meniscal Replacement After Incomplete Meniscal Loss
NA · Privatpraxis für Knie und Schulterchirurgie · Sven Behrendt · NCT06376422 Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Ce
Phase 3 · GEFOS Gesellschaft f. onkologische Studien ( Site 1005) · Merck Sharp & Dohme LLC · NCT06422143

Look up another city

Look up another condition